Fisher Andrew

CIK 00020143011 companyLONDON, X0

SEC Profile

Transactions

Companies

Filings

CIK

0002014301

Recent Transactions

30 trades

Exercise/Conversion
Verona Pharma plc$VRNA
Restricted Share Unit
2025-10-07−146,168→ 0 total
Disposition to Issuer
Verona Pharma plc$VRNA
Ordinary Shares
2025-10-07−931,984→ 0 total
Disposition to Issuer
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-10-07−2,240,000→ 0 total
Exercise/Conversion
Verona Pharma plc$VRNA
Restricted Share Unit
2025-10-07−618,760→ 0 total
Award
Verona Pharma plc$VRNA
Restricted Share Unit
2025-10-07+618,760→ 618,760 total
Exercise/Conversion
Verona Pharma plc$VRNA
Restricted Share Unit
2025-10-07−167,056→ 0 total
Disposition to Issuer
Verona Pharma plc$VRNA
Ordinary Shares
2025-10-07−417,903→ 0 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-10-07+931,984→ 931,984 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-08-01+20,888→ 427,487 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2025-08-01$13.14/sh−9,584→ 417,903 total
Exercise/Conversion
Verona Pharma plc$VRNA
Restricted Stock Units
2025-08-01−20,888→ 146,168 total
Tax Payment
Verona Pharma plc$VRNA
Ordinary Shares
2025-07-08$11.44/sh−39,464→ 406,599 total
Exercise/Conversion
Verona Pharma plc$VRNA
Restricted Share Units
2025-07-07−86,064→ 167,056 total
Award
Verona Pharma plc$VRNA
Restricted Share Units
2025-07-07+253,120→ 253,120 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-07-07+86,064→ 446,063 total
Exercise/Conversion
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-06-16−80,000→ 2,240,000 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-06-16$2.01/sh+80,000→ 439,999 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2025-06-16$11.53/sh−80,000→ 359,999 total
Exercise/Conversion
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-05-15−80,000→ 2,320,000 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-05-15$2.01/sh+80,000→ 439,999 total
Exercise/Conversion
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-05-15−80,000→ 2,320,000 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-05-15$2.11/sh+80,000→ 439,999 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2025-05-15$8.57/sh−80,000→ 359,999 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2025-04-29$8.98/sh−26,072→ 359,993 total
Exercise/Conversion
Verona Pharma plc$VRNA
Restricted Share Units
2025-04-29−86,064→ 167,056 total
Award
Verona Pharma plc$VRNA
Restricted Share Units
2025-04-29+253,120→ 253,120 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-04-29+86,064→ 386,065 total
Gift
Verona Pharma plc$VRNA
Ordinary Shares
2025-03-19+1→ 300,001 total
Award
Verona Pharma plc$VRNA
Ordinary Shares
2024-10-30+300,000→ 300,000 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2024-04-01+2,400,000→ 2,400,000 total

Companies

Verona Pharma plc
General Counsel
$VRNA

Recent Filings

Address

3 MORE LONDON RIVERSIDE

LONDON, X0, SE1 2RE

View on SEC.gov